title: The Density Code for the Development of a Vaccine?
abstract: The development of prophylactic vaccines remains largely empirical in nature and rarely have general rules been applied in the strategic decision and the formulation of a viral vaccine. Currently, there are a total of 15 virus agents from 12 unique virus families with vaccines licensed by the U.S. Food and Drug Administration. Extensive structural information on these viral particles and potential mechanisms of protection are available for the majority of these virus pathogens and their respective vaccines. Here I review the quantitative features of these viral surface antigens in relation to the molecular mechanisms of B-cell activation and point out a potential correlation between the density of immunogenic proteins displayed on the surface of the vaccine antigen carrier and the success of a vaccine. These features help us understand the humoral immunity induced by viral vaccines on a quantitative ground and re-emphasize the importance of antigen density on the activation of the immune system. Although the detailed mechanisms behind this phenomenon remain to be explored, it implies that both the size of antigen carriers and the density of immunogenic proteins displayed on these carriers are important parameters that may need to be optimized for the formulation of a vaccine.
authors.affiliation: Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109; Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109; Department of Biophysics, University of Michigan, Ann Arbor, Michigan 48109. Electronic address: chengwe@umich.edu.
authors.forename: Wei
authors.initials: W
authors.lastname: Cheng
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000276:immunology* / Q000378:metabolism; D001402:B-Lymphocytes / Q000276:immunology / Q000378:metabolism; D004339:Drug Compounding; D055808:Drug Discovery / Q000379:methods / Q000639:trends*; D006801:Humans; D056724:Immunity, Humoral / Q000187:drug effects / Q000276:immunology*; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*; D014777:Virus Diseases / Q000276:immunology / Q000517:prevention & control
chemical_list: D000956:Antigens, Viral; D014765:Viral Vaccines
keywords: B-cell activation; B-cell receptor; immune response; immunology; nanoparticles; particulate antigen; protein density; vaccine delivery; vaccines